Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.
暂无分享,去创建一个
M. Taskinen | C. Barbagallo | D. Noto | R. Vigneri | F. Yin | A. Carroccio | R. Spina | M. Péterfy | P. Tarugi | S. Squatrito | M. Averna | H. Hilden | A. Cefalù | M. Arpi
[1] F. Yin,et al. A quantitative assay measuring the function of lipase maturation factor 1 , 2009, Journal of Lipid Research.
[2] S. Young,et al. Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[3] P. Pajukanta,et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia , 2007, Nature Genetics.
[4] S. Yusuf,et al. Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650) , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[5] J. Brunzell,et al. Clinical practice. Hypertriglyceridemia. , 2007, The New England journal of medicine.
[6] P. Barter,et al. Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[7] R. Hegele,et al. Hypertriglyceridemia: its etiology, effects and treatment , 2007, Canadian Medical Association Journal.
[8] S. Young,et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. , 2007, Cell metabolism.
[9] T. Olivecrona,et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.
[10] H. Mao,et al. The cld mutation: narrowing the critical chromosomal region and selecting candidate genes , 2006, Mammalian Genome.
[11] S. Bertolini,et al. A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. , 2006, Atherosclerosis.
[12] L. Pennacchio,et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. , 2005, The Journal of clinical investigation.
[13] G. Livolti,et al. Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia , 2005 .
[14] A. Cantafora,et al. Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[15] Kenichi Yoshida,et al. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.C200010-JLR200 , 2002, Journal of Lipid Research.
[16] H. Mao,et al. Maturation of Lipoprotein Lipase in the Endoplasmic Reticulum , 2002, The Journal of Biological Chemistry.
[17] Jonathan C. Cohen,et al. An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.
[18] M. Doolittle,et al. cld and lec23 are disparate mutations that affect maturation of lipoprotein lipase in the endoplasmic reticulum. , 1999, Journal of lipid research.
[19] K. Reue,et al. Naturally occurring mutations in mice affecting lipid transport and metabolism. , 1996, Journal of lipid research.
[20] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[21] M. Taskinen. Lipoprotein lipase in diabetes. , 1987, Diabetes/metabolism reviews.
[22] K. Artzt,et al. Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. , 1983, Science.
[23] P. Kinnunen,et al. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[24] S. Lehnart,et al. Why Do We Still Have a Maternally Inherited Mitochondrial DNA ? Insights from Evolutionary Medicine , 2007 .